Yuval Cohen
CEO & DirectorDr. Yuval Cohen, Ph.D. has been the Chief Executive Officer and Director at Corbus Pharmaceuticals Holdings, Inc. since April 11, 2014. Dr. Cohen served as Senior Vice President at Celsus Therapeutics Plc (formerly, Morria Biopharmaceuticals Plc) from February 2013 to June 2013 and served as its President and Co-founder since January 12, 2005 until February 2013. Dr. Cohen served as the Managing Director of Celsus Therapeutics Plc. Dr. Cohen has been the driving force behind transforming MFAID technology into the biotech start-up that is Morria. Dr. Cohen's background in both molecular biology and protein biochemistry and his interest in biotechnology enable him to understand and convey both the nature and potential of this technology. His responsibility is to develop the anti-inflammatory propriety technology platform to its full potential with various strategic partners. Dr. Cohen is committed to making Morria an unprecedented success. Dr. Cohen served as an Interim Chief Executive Officer at Celsus Therapeutics Plc. He served as a Director of Celsus Therapeutics Plc from January 12, 2005 to December 10, 2013. Dr. Cohen worked in the laboratories of Wolf Brandt (University of Cape Town) and Dietrich Averbeck (Curie Institute) on chromatin and DNA repair processes. He is also a recipient of a certificate in Business Management and Entrepreneurship from the Cape Technikon (awarded with distinction, 2002). Apart from his industry experience, he is also the author of a number of peer-reviewed papers and reviews as well as listed inventor on a number of patents. Dr. Cohen Awards includes: Amelia Schenkman Foundation Merit bursary, Dean's List, Foundation for Research and Development bursary, Boursier du Gouvernement Français (French Ministry of Foreign Affairs), Young Scientist travel award Brussels 2001 (L-MOV), San Francisco 2000 (ASP). Dr. Cohen holds Israeli and South African nationalities and is fluent in English, French, Hebrew and Romanian. He holds BSc (Hons) in Microbiology and Biochemistry from University of Cape Town. Dr. Cohen holds a PhD (cum laude) from the Curie Institute of Cancer Research and the University of Paris V in Medical Science.
Positions
- Company NameCorbus Pharmaceuticals Holdings, Inc.Stock CodeCRBPPositionCEO & DirectorColleagues
- RSRachelle Suzanne JacquesIndependent Chairman of the Board
- SFSean F. MoranChief Financial Officer
- IHIan HodgsonChief Operating Officer
- GSG. Scott GoekenGeneral Counsel & Corporate Secretary
- CBChristina BertschVice President of Human Resources
- JKJohn Kenneth JenkinsIndependent Director
- AAAnne AltmeyerIndependent Director
- WKWinston KungIndependent Director
